Latest SUPN reports update at 2023-11-08: 2023-Q32022-Q42022-Q3
Supernus Pharmaceuticals logo

Supernus Pharmaceuticals SUPN

$ 30.07 2.59%

Country

usaUSA

IPO year

2012

Industry

Drug manufacturers

Stock Exchange

NASDAQ GLOBALSPB

CEO

Mr. Jack Khattar

Employees in the company

464

Shares

53.7 M

Market Cap[1]

$ 1.61 B

EBITDA (LTM)

$ 16.8 M

P/E (LTM)

785.67

P/S (LTM)

2.04

EPS (LTM)

0.03

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.